WeRide Inc. (NASDAQ:WRD) is one of the Top 15 Chinese Companies on US Exchanges. On January 27, WeRide Inc. (NASDAQ:WRD) announced the launch of its proprietary general-purpose simulation model, WeRide Genesis. The company’s latest model helps in connecting physical AI and generative AI. This development will assist in linking the real and simulated worlds to enhance the growth, training, and validation of autonomous vehicles (AVs). Dr. Yan Li, Co-Founder and CTO of WeRide, said: WeRide Inc. Launches Its ...

Core Insights - Trane Technologies plc is a leader in climate innovation, focusing on sustainable solutions for buildings, homes, and transportation, particularly in the HVAC sector [1] Financial Performance - Oppenheimer maintained an "Outperform" rating for Trane, raising the price target to $468 from $460 after the company reported earnings per share of $2.86, exceeding the consensus estimate of $2.82 [2][3][6] - Trane's quarterly revenue reached $5.14 billion, surpassing analyst predictions of $5.09 billion, indicating strong financial performance [3][6] - The company achieved a return on equity of 37.04% and a net margin of 13.93%, reflecting robust financial metrics [4][6] Market Activity - The stock price of Trane was $426.07, showing an 8.09% increase, with fluctuations between a low of $406.50 and a high of $429.13 on the trading day [4][5] - The market capitalization of Trane is approximately $94.48 billion, with a trading volume of 4.41 million shares, indicating strong investor interest [5]

LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ARDENT INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS T ...

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Tenpoint Therapeutics Ltd.’s Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as Brimochol PF, the first and only dual-agent eye drop for presbyopia in adults.Presbyopia, the gradual loss of near vision that typically begins around age 45, affects about two billion people globally and 128 million people in the U.S.Yuvezzi is expected to be broadly commercially available in the U.S. in the second q ...

This Fed horse race has swung a bunch of different ways since the process began last September. Kevin Walsh is a former Fed governor, has a reputation as a bit of a maverick. He believes, basically that the Fed needs kind of a housecleaning.This isn't the first time you've heard me in the last decade say we need regime change at the Fed. It's not just about a person. It's about an approach to economics. It's about approach to what they're doing.And I'm troubled when I see them moving the goalposts. He's mos ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. $1,000. That's all it would have taken to get meaningful exposure to one of the most explosive stock runs of the AI era. When ChatGPT launched in late 2022, Nvidia was already a known name in gaming and data-center chips. What most investors didn't fully grasp yet was that Nvidia was about to become the backbone of the generative AI boom, supplying the computing power that would train and run large languag ...

"At very high housing costs and income levels, percentage of income as a rule of thumb starts to fall apart," one user wrote. Another added, "Doctor and a big law associate? Pretty sure you'll be fine."Trending: Arrived Home's Private Credit Fund’s has historically paid an annualized dividend yield of 8.1%* , which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum."She's a one-and-done house person," he explained, noting that she's emotionally ready to ...

Key Takeaways DaVita's Q4 2025 is expected to benefit from improved treatment mix and aged claims resolution.DVA may see stronger earnings driven by higher revenue per treatment and disciplined cost control.DaVita's tech investments and IKC timing could help offset pressure from missed treatments and mortality.DaVita Inc. (DVA) is scheduled to report fourth-quarter 2025 results on Feb. 2, 2026, after the closing bell.In the last reported quarter, the company’s earnings per share (EPS) of $2.51 lagged the Za ...

Key Takeaways Comcast delivered a Q4 earnings and revenue beat, fueled by strong Theme Parks and Peacock performance.CMCSA's Theme Parks revenues jumped around 22%, while Peacock posted record revenue and subscriber growth.Comcast faced pressure from broadband subscriber losses, weaker Studios performance and margin compression.Comcast (CMCSA) reported fourth-quarter 2025 adjusted EPS of 84cents, which beat the Zacks Consensus Estimate by 12% and declined 12.4% year over year.Revenues of $32.31 billion beat ...